Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.53 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.51 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.51 |
| ▸ | TERT | O14746 | 3/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.50 |
| ▸ | PPARG | P37231 | 3/20 | 0.50 |
| ▸ | PPARD | Q03181 | 3/20 | 0.50 |
| ▸ | PPARA | Q07869 | 3/20 | 0.50 |
| ▸ | FAAH | O00519 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | TOP1 | P11387 | 2/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL874553 | 1.00 | EPHX2 (0.53) | EPHX2ALOX5OXER1TERTPTPN1 | |
| SCHEMBL1867708 | 1.00 | EPHX2 (0.53) | EPHX2ALOX5OXER1TERTPTPN1 | |
| SCHEMBL31512514 | 0.98 | EPHX2 (0.55) | EPHX2TERTPTPN1PPARGPPARD | |
| SCHEMBL17449343 | 0.98 | EPHX2 (0.55) | EPHX2TERTPTPN1PPARGPPARD | |
| SCHEMBL31512536 | 0.98 | EPHX2 (0.55) | EPHX2TERTPTPN1PPARGPPARD | |
| SCHEMBL23700185 | 0.98 | EPHX2 (0.55) | EPHX2TERTPTPN1PPARGPPARD | |
| SCHEMBL23700184 | 0.98 | EPHX2 (0.55) | EPHX2TERTPTPN1PPARGPPARD | |
| SCHEMBL2832461 | 0.98 | EPHX2 (0.55) | EPHX2TERTPTPN1PPARGPPARD | |
| SCHEMBL15369489 | 0.98 | EPHX2 (0.55) | EPHX2TERTPTPN1PPARGPPARD | |
| SCHEMBL2832460 | 0.98 | EPHX2 (0.55) | EPHX2TERTPTPN1PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 196 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118995170-A | Emulsifying viscosity reducer and application thereof | 四川海盾石油新技术开发有限公司 | 2024-11-22 | — | — | CN | claimed |
| US-20240306688-A1 | METHOD OF MITIGATING OFF-ODORS | GIVAUDAN SA (CH) | 2024-09-19 | — | — | US | claimed |
| EP-4391827-A1 | METHOD OF MITIGATING OFF-ODORS | Givaudan SA (CH) | 2024-07-03 | — | — | EP | claimed |
| CN-117897055-A | Method for reducing abnormal odor | 奇华顿股份有限公司 | 2024-04-16 | — | — | CN | claimed |
| EP-4257663-A1 | FOOD CONTACT SURFACE SANITIZING LIQUID | The Procter & Gamble Company (US) | 2023-10-11 | — | — | EP | claimed |
| WO-2023025549-A1 | METHOD OF MITIGATING OFF-ODORS | GIVAUDAN SA (CH) | 2023-03-02 | — | — | WO | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| EP-3309245-A1 | ENCAPSULATES | The Procter & Gamble Company (US) | 2018-04-18 | — | — | EP | claimed |
| EP-2512406-B1 | PERFUMES AND PERFUME ENCAPSULATES | PROCTER & GAMBLE (US) | 2018-01-24 | — | — | EP | claimed |
| EP-2512406-A1 | PERFUMES AND PERFUME ENCAPSULATES | The Procter & Gamble Company (US) | 2012-10-24 | — | — | EP | claimed |
| EP-2513280-A1 | COMPOSITION COMPRISING ENCAPSULATES, AND PROCESS FOR MAKING THEM | The Procter & Gamble Company (US) | 2012-10-24 | — | — | EP | claimed |
| WO-2011075556-A1 | COMPOSITION COMPRISING ENCAPSULATES, AND PROCESS FOR MAKING THEM | THE PROCTER & GAMBLE COMPANY (US) | 2011-06-23 | — | — | WO | claimed |
| WO-2011075551-A1 | PERFUMES AND PERFUME ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2011-06-23 | — | — | WO | claimed |
| US-6126930-A | REDUCING TRIGEMINAL STIMULATION FROM AN ATOMIZED ALCOHOL | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-03 | — | — | US | claimed |
| EP-0986367-A1 | SPRAY COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2000-03-22 | — | — | EP | claimed |
| WO-1998035651-A1 | SPRAY COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-08-20 | — | — | WO | claimed |
| US-20260033524-A1 | FLAVOR MODIFYING COMPOSITIONS | CORN PRODUCTS DEV INC (US) | 2026-02-05 | — | — | US | disclosed |
| EP-4435080-B1 | A PROCESS OF MAKING A SALTED SPRAY-DRIED PERFUME MICROCAPSULE PARTICLE | PROCTER & GAMBLE (US) | 2025-08-20 | — | — | EP | disclosed |
| WO-1997026926-A1 | AIR FRESHENER COMPOSITION CONTAINING A FIBER PAD | EASTMAN CHEMICAL COMPANY (US) | 1997-07-31 | — | — | WO | disclosed |
| US-3953499-A | 8,12-Dialkyl-PGE, and PGF1.sub.α | THE UPJOHN COMPANY (US) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260033524-A1 | FLAVOR MODIFYING COMPOSITIONS | TAS2R42, TAS2R7, TAS2R31 | EPHX2 3524/4885ALOX5 4430/4885OXER1 3394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.